Search results for: 'cell ad g01e therapeutics market'
- Related search terms
- marketing strategy hotel industry year 1999
- market research q1 2022 ® ion 28
- cell biolog research market global 2014 2030
- marketing strategy homes industry year 1.09
- cell biolog research market global 2014 2020
-
24 Oct 2018  |  North America  |  Market Research
Growth Opportunities in the Global Cell Therapy Market, Forecast to 2025
A Robust Product Pipeline Creating Opportunities for Ground-breaking Combination Therapies is Set to Revolutionize the Global Cell Therapy Market
The global pharmaceuticals industry is continuously evolving to meet the requirements of a changing disease landscape. With the increasing prevalence of chronic infectious diseases and cancer, market needs are shifting from traditional small molecules to novel large molecule therapies, with cell therapies dominating the space. This study presents a...
$4,950.00 -
08 Dec 2015  |  Asia Pacific  |  Market Research
A Product and Pipeline Analysis of the Human Plasma-derived Therapeutics Market
Launch of Novel Immunoglobulin Products and Increasing Awareness of Therapeutic Options to Drive Double-digit Market Growth
The Chinese pharmaceutical market is expected to be the third-largest in the world in 2013. This research service analyzes various aspects of the Chinese pharmaceutical market between 2007 and 2016. Rising income, improving healthcare infrastructure, and insurance systems are some factors that drive this market. The study discusses in detail the ma...
$6,000.00 -
29 Jun 2023  |  Global  |  Technology Research
Emerging Landscape of Targeted Protein Degradation Therapeutics
Rapid Technology Advances Bolster a Robust Therapeutic Pipeline
This Frost & Sullivan research report provides an in-depth analysis of the emerging targeted protein degradation (TPD) space. TPD strategies enable treating various diseases not yet treatable via conventional approaches by attacking disease-causing proteins in a controlled manner, thus reducing the risk of side effects. It is estimated that 80%...
$4,950.00 -
14 Nov 2025  |  Global  |  Technology Research
Emerging Therapeutic Platforms and AI-driven Innovations in Biologics, Oncology, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in oncology, immunology, autoimmune disorders, and precision medicine, highlighting next-generation biologics, bispecific antibodies, kinase inhibitors, molecular glues, and antibody engineering platforms. The...
$950.00 -
02 Dec 2019  |  North America  |  Market Research
The Challenges and Best Practices for Inserting Ads into OTT Downloadable Videos
AVOD Providers are Unsure About Integrating into an Ad-supported Business Model
The importance of download as a feature within OTT services and how it may be a big business opportunity for AVOD providers cannot be overstated. But this will only hold true if the technology can work seamlessly with existing apps and ad-based revenue models. More OTT services, both AVOD and SVOD, must start including downloads as an option, to en...
$1,500.00 -
23 Jan 2026  |  Global  |  Technology Research
Next-Generation Therapeutic Platforms: AI-Enabled Drug Discovery, Small molecules, Deep Proteomics, RNA Engineering, and Targeted Immunomodulation
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers provides strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision therapeutics. It highlights advances in AI-enabled diagnostics, metabolic reprogramming, small molecules, deep proteomics, RNA disco...
$950.00 -
18 Nov 2022  |  Europe  |  Market Research
European Anaerobic Digestion (AD) and Biogas Production Growth Opportunities
The EU’s Green Taxonomy and the REPowerEU Plan have Put the Spotlight on Long-term Investments in the Sustainability of Renewable Natural Gas (RNG) Production through AD
Several European countries, including Germany, the United Kingdom, and Denmark, are at the forefront of leveraging the potential of biogas produced through the anaerobic digestion (AD) of energy crops, agricultural waste, organic waste, and sewage sludge. Subsidies and incentives are the key growth drivers. As part of its Net Zero by 2050 Strategy,...
$2,450.00 -
26 Jun 2019  |  Global  |  Technology Research
Technological Advancements and Emerging Applications of Fuel Cells
Increasing Durability and Cost Reduction Accelerate Commercialisation of Fuel Cell in Various Applications
There is rising demand for innovative, efficient and cleaner power generation technologies. Electrochemical energy technologies such as supercapacitors , batteries and fuel cells have gained a significant interest in last decades and are considered important to enable alternative power sources. Fuel cells are one of the most promising energy gener...
$4,950.00 -
07 Jul 2020  |  Global  |  Technology Research
Competitive Landscape Analysis of Recent Cell and Gene Therapy Innovations
Emerging Chimeric Antigen Receptor (CAR) T-cell Therapy Platforms
This research identifies some the key developments across CAR-T cell therapies and provides insights across technological, IP, and investment landscapes. The study also provides an analysis of the competitive landscape while highlighting the key growth opportunities within the CAR-T cell therapy platform.
$4,950.00 -
18 Sep 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in AI-Enabled Discovery and Diagnostics, Precision Therapeutics, and Next-Generation Vaccine Platforms
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming AI-enabled discovery, precision diagnostics, cell engineering, targeted therapeutics, vaccines, and skin health across oncology, metabolic disease, rare disorders, neuropsychiatry, and ne...
$950.00